{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:04:29Z","timestamp":1790935469215,"version":"4.1.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI20C1496"],"award-info":[{"award-number":["HI20C1496"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Osteoporosis is a common comorbidity in patients with SLE, and bone loss in patients with SLE has a multifactorial aetiology. This study aimed to evaluate the therapeutic efficacy of denosumab in patients with SLE with osteoporosis and to analyse the factors influencing therapeutic efficacy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 166 patients with SLE with osteoporosis who initiated denosumab between January 2016 and December 2023 were included. Changes in the T-score and areal bone mineral density (BMD) at the lumbar spine, total hip and femur neck from denosumab initiation to 12 months were measured. Correlation analysis was performed between the degree of BMD improvement and covariates including SLE-specific factors such as SLE duration, SLE Disease Activity Index 2000 (SLEDAI-2K) score, glucocorticoid dose and hydroxychloroquine use. Multiple linear regression analysis was conducted to identify predictors of the therapeutic efficacy of denosumab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Denosumab significantly increased BMD and decreased bone turnover markers at 12 months compared with baseline. The degree of BMD improvement revealed a significant negative correlation with SLEDAI-2K score, hydroxychloroquine use, prior osteoporosis treatment and baseline BMD values. In contrast, body mass index and c-telopeptide of collagen type 1 levels were positively correlated with the degree of BMD improvement. Higher baseline BMD values, SLEDAI-2K scores and hydroxychloroquine use were significant predictors of attenuated BMD improvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study suggests that denosumab is an effective treatment option for osteoporosis in patients with SLE. The therapeutic efficacy of denosumab can be predicted by baseline BMD values, SLEDAI-2K scores and hydroxychloroquine use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2024-001438","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:35:31Z","timestamp":1737585331000},"page":"e001438","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-6395","authenticated-orcid":false,"given":"Jiwon","family":"Yang","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-4538","authenticated-orcid":false,"given":"Youngjae","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Jooha","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeon","family":"Ju","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Uk","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"2025091511414199000_12.1.e001438.1","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.3390\/ijms23105804","article-title":"Bone Involvement in Systemic Lupus Erythematosus","volume":"23","author":"Rella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025091511414199000_12.1.e001438.2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldaa005"},{"key":"2025091511414199000_12.1.e001438.3","first-page":"486","article-title":"Osteoporosis in patients with systemic lupus erythematosus","volume":"11","author":"Garc\u00eda-Carrasco","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"2025091511414199000_12.1.e001438.4","doi-asserted-by":"crossref","first-page":"510514","DOI":"10.1155\/2015\/510514","article-title":"Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus","volume":"2015","author":"Sun","year":"2015","journal-title":"Biomed Res Int"},{"key":"2025091511414199000_12.1.e001438.5","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000098","article-title":"Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus","volume":"3","author":"Carli","year":"2016","journal-title":"Lupus Sci Med"},{"key":"2025091511414199000_12.1.e001438.6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10067-008-0984-z","article-title":"Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus","volume":"28","author":"Mendoza-Pinto","year":"2009","journal-title":"Clin Rheumatol"},{"key":"2025091511414199000_12.1.e001438.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2587-z"},{"key":"2025091511414199000_12.1.e001438.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors","volume":"15","author":"Gu","year":"2019","journal-title":"Arch Osteoporos"},{"key":"2025091511414199000_12.1.e001438.9","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12022"},{"key":"2025091511414199000_12.1.e001438.10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025091511414199000_12.1.e001438.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"2025091511414199000_12.1.e001438.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044459"},{"key":"2025091511414199000_12.1.e001438.13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2169\/internalmedicine.56.7797","article-title":"Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids","volume":"56","author":"Sawamura","year":"2017","journal-title":"Intern Med"},{"key":"2025091511414199000_12.1.e001438.14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2015.03.002","article-title":"Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial","volume":"75","author":"Mok","year":"2015","journal-title":"Bone"},{"key":"2025091511414199000_12.1.e001438.15","doi-asserted-by":"crossref","first-page":"799575","DOI":"10.3389\/fimmu.2021.799575","article-title":"The Efficacy of Denosumab in Patients With Rheumatoid Arthritis: A Systematic Review and Pooled Analysis of Randomized or Matched Data","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"2025091511414199000_12.1.e001438.16","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkab099","article-title":"Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis","volume":"5","author":"Yagita","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2025091511414199000_12.1.e001438.17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/mr\/road014","article-title":"Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort","volume":"34","author":"Nakajima","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2025091511414199000_12.1.e001438.18","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/rheumatology\/keaa705","article-title":"Fracture risk in systemic lupus erythematosus patients over 28 years","volume":"60","author":"Garelick","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025091511414199000_12.1.e001438.19","first-page":"1320","article-title":"Fragility fractures in lupus patients: Associated factors and comparison of four fracture risk assessment tools","volume":"32","author":"Ceccarelli","year":"2023","journal-title":"Lupus (Los Angel)"},{"key":"2025091511414199000_12.1.e001438.20","first-page":"223","article-title":"The potential causal association between systemic lupus erythematosus and endocrine and metabolic disorders in the East Asian population: A bidirectional two-sample Mendelian randomization study","volume":"33","author":"Wang","year":"2024","journal-title":"Lupus (Los Angel)"},{"key":"2025091511414199000_12.1.e001438.21","doi-asserted-by":"crossref","first-page":"832127","DOI":"10.1155\/2015\/832127","article-title":"Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases","volume":"2015","author":"Amarasekara","year":"2015","journal-title":"J Immunol Res"},{"key":"2025091511414199000_12.1.e001438.22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00223-017-0322-z","article-title":"Bone Disease in Connective Tissue Disease\/Systemic Lupus Erythematosus","volume":"102","author":"Bultink","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"2025091511414199000_12.1.e001438.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"2025091511414199000_12.1.e001438.24","doi-asserted-by":"crossref","unstructured":"Kanis JA . 4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a who report. WHO Study Group; 1994.368\u201381. doi:10.1007\/BF01622200","DOI":"10.1007\/BF01622200"},{"key":"2025091511414199000_12.1.e001438.25","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2025091511414199000_12.1.e001438.26","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.42646","article-title":"2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid\u2010Induced Osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025091511414199000_12.1.e001438.27","first-page":"227","article-title":"Osteoporosis in systemic lupus erythematosus: prevention and treatment","volume":"10","author":"Sen","year":"2001","journal-title":"Lupus (Los Angel)"},{"key":"2025091511414199000_12.1.e001438.28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41413-024-00352-6","article-title":"Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects","volume":"12","author":"Yao","year":"2024","journal-title":"Bone Res"},{"key":"2025091511414199000_12.1.e001438.29","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jcp.26028","article-title":"Hydroxychloroquine affects bone resorption both in vitro and in vivo","volume":"233","author":"Both","year":"2018","journal-title":"J Cell Physiol"},{"key":"2025091511414199000_12.1.e001438.30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6065\/apem.2346060.030","article-title":"Factors affecting bone mineral density in children and adolescents with systemic lupus erythematosus","volume":"29","author":"Park","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2025091511414199000_12.1.e001438.31","first-page":"106","article-title":"Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus","volume":"14","author":"Mok","year":"2005","journal-title":"Lupus (Los Angel)"},{"key":"2025091511414199000_12.1.e001438.32","doi-asserted-by":"crossref","first-page":"101090","DOI":"10.1016\/j.bonr.2021.101090","article-title":"Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study","volume":"14","author":"Tsuchiya","year":"2021","journal-title":"Bone Rep"},{"key":"2025091511414199000_12.1.e001438.33","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1543"},{"key":"2025091511414199000_12.1.e001438.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.06.027"},{"key":"2025091511414199000_12.1.e001438.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-00985-8"},{"key":"2025091511414199000_12.1.e001438.36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jbmr\/zjae068","article-title":"Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project","volume":"39","author":"Schini","year":"2024","journal-title":"J Bone Miner Res"},{"key":"2025091511414199000_12.1.e001438.37","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.251"},{"key":"2025091511414199000_12.1.e001438.38","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00774-020-01119-9","article-title":"Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status","volume":"38","author":"Sugimoto","year":"2020","journal-title":"J Bone Miner Metab"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2024-001438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:41:49Z","timestamp":1757961709000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2024-001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,22]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/lupus-2024-001438"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2024-001438","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}